Risk of fatal adverse events after H1N1 influenza vaccination

Clinical Infectious Diseases

Volumn 50, Issue 11, 2010, Pages 1548-1549

  Nakada, Haruka ^a   Narimatsu, Hiroto ^c   Tsubokura, Masaharu ^d   Murashige, Naoko ^b   Matsumura, Tomoko ^a   Kodama, Yuko ^a   Kishi, Yukiko ^a   Kami, Masahiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Cabinet Office   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

H1N1 INFLUENZA VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

DRUG FATALITY; DRUG SAFETY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1 INFECTION; LETTER; PRIORITY JOURNAL; VACCINATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; RISK ASSESSMENT; VACCINATION;

EID: 77951830850     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/652719     Document Type: Letter

References (1)

1. Centers for Disease Control and Prevention. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1351-1356